Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

69.46 +0.52 (+0.75%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,421,942
Open 69.40
Bid (Size) 69.51 (1)
Ask (Size) 69.70 (6)
Prev. Close 68.94
Today's Range 69.08 - 70.63
52wk Range 62.34 - 142.00
Shares Outstanding 400,700,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U
From Dexcom, Inc.
Via Business Wire
Kirby McInerney LLP Notifies Dexcom Inc. (DXCM) Investors of Class Action Filing and Encourages Investors to Contact the Firm
From Kirby McInerney LLP
Via Business Wire

Performance

YTD
-43.57%
-43.57%
1 Month
-10.59%
-10.59%
3 Month
-40.45%
-40.45%
6 Month
-48.23%
-48.23%
1 Year
-27.11%
-27.11%

More News

Read More
Uh-Oh! Alphabet Is Selling Its Stake in 2 Historically High-Flying Artificial Intelligence (AI) Stocks
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
$100 Invested In DexCom 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Is DexCom a Millionaire-Maker Stock?
Via The Motley Fool
DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Methode Electronics, DexCom, Endava, and Orthofix and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
2 Unstoppable Healthcare Stocks to Buy Right Now for Less Than $200
Via The Motley Fool
Faruqi & Faruqi Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - DXCM
From Faruqi & Faruqi LLP
Via GlobeNewswire
3 Reasons DexCom Looks Like a No-Brainer Buy Right Now
Via The Motley Fool
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Methode Electronics, DexCom, Endava, and Orthofix and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission
From DexCom, Inc.
Via Business Wire
Kirby McInerney LLP Reminds Dexcom Inc. (DXCM) Investors of Class Action Filing and Encourages Investors to Contact the Firm
From Kirby McInerney LLP
Via GlobeNewswire
DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom
From Faruqi & Faruqi LLP
Via GlobeNewswire
Jim Cramer Doesn't Like Carnival Right Now: Royal Caribbean Is 'The One You Want'
Via Benzinga
DXCM Lawsuit Reminder: Robbins LLP Encourages DexCom Inc. Stockholders to Seek Counsel for Class Action Lawsuit
From Robbins LLP
Via GlobeNewswire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM
From The Rosen Law Firm PA
Via GlobeNewswire
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Abbott's 'Transformative' Move And Answer To Dexcom's Newest Device
Via Investor's Business Daily
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Methode Electronics, DexCom, Endava, and Orthofix and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Dexcom to Showcase Transformational Impact of Dexcom CGM Technology at the EASD 2024 Conference Symposium
From DexCom, Inc.
Via Business Wire
DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Shareholder Rights Law Firm Robbins LLP Urges DXCM Stockholders with Large Losses to Contact the Firm for Information About the DexCom Inc. Lawsuit
From Robbins LLP
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Methode Electronics, DexCom, Endava, and Orthofix and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.